Healthcare -
Biotechnology - NASDAQ - US
$ 8.03
-0.623 %
$ 178 M
Market Cap
-3.68
P/E
INMB - OPERATING INCOME
Operating Income INMB - INmune Bio, Inc.
-29.7 M
LAST VALUE
-1.00%
2 YEAR CAGR
-19.04%
5 YEAR CAGR
0.00%
10 YEAR CAGR